By administering high doses of intravenous Vitamin C, researchers were able to extend the average prognosis from 8 months to ...

intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from eight months to 16 months. This is a deadly disease with very ...

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

High-dose intravenous vitamin C doubles survival in metastatic pancreatic cancer, extending life without added toxicity or ...

The phase-two clinical trial found that adding high-dose, intravenous vitamin C to chemotherapy doubles the overall survival ...

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...

intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from eight months to 16 months. “This is a deadly disease with ...

Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

After spending Monday night in a veterinary hospital, he's scheduled to have another round of intravenous Vitamin C treatment, which Herbstreit said will hopefully "flush the toxics from his body ...